Trichostatin A, a histone deacetylase inhibitor, reverses epithelial-mesenchymal transition in colorectal cancer SW480 and prostate cancer PC3 cells

Biochemical and Biophysical Research Communications

Volumn 456, Issue 1, 2015, Pages 320-326

  Wang, Xiaoxiong ^a   Xu, Jun ^a   Wang, Hao ^b   Wu, Long ^a   Yuan, Weiqi ^a   Du, Jun ^c   Cai, Shaohui ^a  

^a JINAN UNIVERSITY   (China)

^b ANHUI PROVINCIAL HOSPITAL   (China)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

Epithelial mesenchymal transition; Histone deacetylase inhibitor; Reverse; Slug; Trichostatin A

Indexed keywords

HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 3; HISTONE DEACETYLASE 4; TRANSCRIPTION FACTOR SLUG; TRICHOSTATIN A; UVOMORULIN; VIMENTIN; CADHERIN; CDH1 PROTEIN, HUMAN; HDAC1 PROTEIN, HUMAN; HDAC2 PROTEIN, HUMAN; HISTONE DEACETYLASE INHIBITOR; HYDROXAMIC ACID; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CELL INVASION; CELL MEMBRANE; CELL MIGRATION; CELL PROLIFERATION; COLORECTAL CANCER CELL LINE; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; DRUG MECHANISM; EPITHELIAL MESENCHYMAL TRANSITION; GENETIC TRANSCRIPTION; PROMOTER REGION; PROSTATE CANCER CELL LINE; PROTEIN EXPRESSION; UPREGULATION; CELL MOTION; COLORECTAL TUMOR; CONFOCAL MICROSCOPY; DOSE RESPONSE; DRUG EFFECTS; GENE EXPRESSION REGULATION; HUMAN; MALE; METABOLISM; PROSTATE TUMOR; TUMOR CELL LINE; TUMOR INVASION;

CADHERINS; CELL LINE, TUMOR; CELL MOVEMENT; COLORECTAL NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE INHIBITORS; HUMANS; HYDROXAMIC ACIDS; MALE; MICROSCOPY, CONFOCAL; NEOPLASM INVASIVENESS; PROMOTER REGIONS, GENETIC; PROSTATIC NEOPLASMS; TRANSCRIPTION FACTORS; VIMENTIN;

EID: 84919649003     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.11.079     Document Type: Article

References (29)

1. A.A. Lane, and B.A. Chabner Histone deacetylase inhibitors in cancer therapy J. Clin. Oncol. 27 2009 5459 5468
2. J. Inokoshi, M. Katagiri, S. Arima, H. Tanaka, M. Hayashi, Y.B. Kim, R. Furumai, M. Yoshida, S. Horinouchi, and S. Omura Neuronal differentiation of neuro 2a cells by inhibitors of cell cycle progression, trichostatin A and butyrolactone I Biochem. Biophys. Res. Commun. 256 1999 372 376
3. S. Radke, S. Perincheri, V. Schulz, B. Lerner, A. Kumar, L. Chandrasekan, D. Tuck, and L. Harris The HDAC inhibitor TSA inhibits cell proliferation, induces apoptosis and down-regulates her2 protein and gene expression as a single agent and in combination with trastuzumab in trastuzumab-sensitive and -resistant breast cancer cell lines Cancer Res. 69 2009 690S
4. W.S. Fortson, S. Kayarthodi, Y. Fujimura, H. Xu, R. Matthews, W.E. Grizzle, V.N. Rao, G.K. Bhat, and E.S.P. Reddy Histone deacetylase inhibitors, valproic acid and trichostatin-A induce apoptosis and affect acetylation status of p53 in ERG-positive prostate cancer cells Int. J. Oncol. 39 2011 111 119
5. H. Xiong, W. Du, Y.-J. Zhang, J. Hong, W.-Y. Su, J.-T. Tang, Y.-C. Wang, R. Lu, and J.-Y. Fang Trichostatin A, a histone deacetylase inhibitor, suppresses JAK2/STAT3 signaling via inducing the promoter-associated histone acetylation of SOCS1 and SOCS3 in human colorectal cancer cells Mol. Carcinog. 51 2012 174 184
6. N.H. Kim, S.-N. Kim, and Y.K. Kim Involvement of HDAC1 in E-cadherin expression in prostate cancer cells; its implication for cell motility and invasion Biochem. Biophys. Res. Commun. 404 2011 915 921
7. J. Behrens, M.M. Mareel, F.M. Van Roy, and W. Birchmeier Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion J. Cell Biol. 108 1989 2435 2447
8. C. Xue, D. Plieth, C. Venkov, C. Xu, and E.G. Neilson The gatekeeper effect of epithelial-mesenchymal transition regulates the frequency of breast cancer metastasis Cancer Res. 63 2003 3386 3394
9. A.F. Logullo, S. Nonogaki, F.S. Pasini, C.A. Bueno De Toledo Osorio, F.A. Soares, and M.M. Brentani Concomitant expression of epithelial-mesenchymal transition biomarkers in breast ductal carcinoma: association with progression Oncol. Rep. 23 2010 313 320
10. C.P. Prasad, G. Rath, S. Mathur, D. Bhatnagar, R. Parshad, and R. Ralhan Expression analysis of E-cadherin, Slug and GSK3 beta in invasive ductal carcinoma of breast BMC Cancer 9 2009
11. J.P. Thiery, and J.P. Sleeman Complex networks orchestrate epithelial-mesenchymal transitions Nat. Rev. Mol. Cell Biol. 7 2006 131 142
12. M. Zeisberg, and E.G. Neilson Biomarkers for epithelial-mesenchymal transitions J. Clin. Invest. 119 2009 1429 1437
13. M. Guarino Epithelial-to-mesenchymal change of differentiation. From embryogenetic mechanism to pathological patterns Histol. Histopathol. 10 1995 171 184
14. J.P. Thiery, H. Acloque, R.Y.J. Huang, and M. Angela Nieto Epithelial-mesenchymal transitions in development and disease Cell 139 2009 871 890
15. M.A. Nieto The snail superfamily of zinc-finger transcription factors Nat. Rev. Mol. Cell Biol. 3 2002 155 166
16. K.M. Hajra, D.Y.S. Chen, and E.R. Fearon The SLUG zinc-finger protein represses E-cadherin in breast cancer Cancer Res. 62 2002 1613 1618
17. C.R. Schmidt, Y.J. Gi, T.A. Patel, R.J. Coffey, R.D. Beauchamp, and A.S. Pearson E-cadherin is regulated by the transcriptional repressor SLUG during Ras-mediated transformation of intestinal epithelial cells Surgery 138 2005 306 312
18. K. Vuoriluoto, H. Haugen, S. Kiviluoto, J.P. Mpindi, J. Nevo, C. Gjerdrum, C. Tiron, J.B. Lorens, and J. Ivaska Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer Oncogene 30 2011 1436 1448
19. H. Wang, H.-S. Wang, B.-H. Zhou, C.-L. Li, F. Zhang, X.-F. Wang, G. Zhang, X.-Z. Bu, S.-H. Cai, and J. Du Epithelial-mesenchymal transition (EMT) induced by TNF-alpha requires AKT/GSK-3 beta-mediated stabilization of snail in colorectal cancer PLoS One 8 2013
20. M. Yoshikawa, K. Hishikawa, T. Marumo, and T. Fujita Inhibition of histone deacetylase activity suppresses epithelial-to-mesenchymal transition induced by TGF-beta 1 in human renal epithelial cells J. Am. Soc. Nephrol. 18 2007 58 65
21. A. Kaimori, J.J. Potter, M. Choti, Z. Ding, E. Mezey, and A.A. Koteish Histone deacetylase inhibition suppresses the transforming growth factor beta 1-induced epithelial-to-mesenchymal transition in hepatocytes Hepatology 52 2010 1033 1045
22. W. Xiao, X. Chen, X. Liu, L. Luo, S. Ye, and Y. Liu Trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and epithelial-mesenchymal transition in retinal pigment epithelium cells J. Cell Mol. Med. 18 2014 646 655
23. Y. Li, Z. Zhao, C. Xu, Z. Zhou, Z. Zhu, and T. You HMGA2 induces transcription factor Slug expression to promote epithelial-to-mesenchymal transition and contributes to colon cancer progression Cancer Lett. 355 2014 130 140
24. Y.-N. Liu, W. Abou-Kheir, J.J. Yin, L. Fang, P. Hynes, O. Casey, D. Hu, Y. Wan, V. Seng, H. Sheppard-Tillman, P. Martin, and K. Kelly Critical and reciprocal regulation of KLF4 and SLUG in transforming growth factor beta-initiated prostate cancer epithelial-mesenchymal transition Mol. Cell. Biol. 32 2012 941 953
25. Y. Jing, D. Cui, W. Guo, J. Jiang, B. Jiang, Y. Lu, W. Zhao, X. Wang, Q. Jiang, B. Han, and S. Xia Activated androgen receptor promotes bladder cancer metastasis via Slug mediated epithelial-mesenchymal transition Cancer Lett. 348 2014 135 145
26. W. Wang, X. Li, W. Zhang, W. Li, M. Yi, J. Yang, Z. Zeng, L.E.C. Wanshura, J.B. McCarthy, S. Fan, P. Zheng, S. Chen, B. Xiang, and G. Li Oxidored-nitro domain containing protein 1 (NOR1) expression suppresses slug/vimentin but not snail in nasopharyngeal carcinoma: inhibition of EMT in vitro and in vivo in mice Cancer Lett. 348 2014 109 118
27. J.-Y. Shih, and P.-C. Yang The EMT regulator slug and lung carcinogenesis Carcinogenesis 32 2011 1299 1304
28. M.R. Hasan, R. Sharma, A. Saraya, T.K. Chattopadhyay, S. DattaGupta, P.G. Walfish, S.S. Chauhan, and R. Ralhan Slug is a predictor of poor prognosis in esophageal squamous cell carcinoma patients PLoS One 8 2013
29. Y. Tang, X. Liang, G. Zhu, M. Zheng, J. Yang, and Y. Chen Expression and importance of zinc-finger transcription factor Slug in adenoid cystic carcinoma of salivary gland J. Oral Pathol. Med. 39 2010 775 780